GeneNews' Q4 Revenues Drop Sharply | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews reported after the close of the market on Friday that revenues for the fourth quarter dropped to C$4,000 (US$4,101) for the three months ended Dec.31, 2010, down from C$410,000 a year ago.

The decline was due to lower revenue from milestone and non-refundable license fees, which plummeted to $C$1,643 from C$398,325, as GeneNews completed all of its historic research agreements.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.